Maricann Group Inc. (CSE:MARI) (OTC:MRRCF) (FRA:75M) announced this morning that Health Canada has granted Maricann Inc. a new licence that removes annual production limits on approved medical cannabis products in its current Langton, Ontario facility. This bullish announcement comes on the heals of the company's recent partnership to create a pharmacy services program that enables pharmacists to counsel and appropriately educate patients in relation to medicinal cannabis.
Per the release, "This new licence increases capacity to 6,250,000 grams on site at any one time. This is an increase from its previous annual licence that limited production to a total of 1,282,000 grams (930kg of dried marihuana and 352 kg of cannabis oil) per year. This new license represents an increase of over 480% of production capacity and is valid until October 9, 2020. Maricann's new facility will house an additional two vaults with 30,000,000 grams of potential licensed storage capacity (15,000,000 grams each)."
"This new license gives us more flexibility as we are able to increase production volume and provide more bulk storage for cannabis products, including processed resin to meet future demand," said Ben Ward, CEO of Maricann. "With the Phase 1 expansion of our state of the art Langton cultivation and production facility nearing completion and with both new vaults now poured and in place, we expect to be able to take full advantage of the scale we are creating. We maintain a highly secure growing environment that meets or exceeds requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR)."
For up-to-the-minute Canadian L.P. news, be sure to subscribe to our free Canadian L.P. Updates newsletter. Be sure to subscribe to one or more of our other free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.